Vancouver, British Columbia--(Newsfile Corp. - March 1, 2016) - Imagin Medical (CSE: IME), formerly Expedition Mining, is the latest new listing on the Canadian Securities Exchange, and trades under the symbol "IME". Imagin Medical is a medical imaging company positioned to radically improve the way physicians detect cancer through the use of endoscopes.
InvestmentPitch.com has produced a "video news alert" which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Imagin" in the search box.
If you cannot view the video above, please visit:
http://www.investmentpitch.com/video/0_r6rumacd/Imagin-Medical-CSE-IME-New-Listing
Imagin's initial target market is bladder cancer, the ninth most common cancer globally, but the most expensive cancer to treat in the U.S.
Blue light was introduced in conjunction with imaging agents, or chemical dyes, for use in cystoscopes and improved the ability to detect even flat cancers and to visualize their margins for more complete removal. However, as the high dose of chemicals required can cause dangerous side effects in patients, the FDA limited use of this technique to one-time per patient, which poses challenges for follow-up exams.
Dr. Stavros Demos, from the renowned Lawrence Livermore National Laboratory, and technical scientific advisor to the company, is the inventor of the i/Blue Imaging System for the accurate visual detection of cancer. The company's advanced ultrasensitive imaging technology is based upon improved optical designs and components, and advanced light sensors, thereby reducing the need for chemical contrast agents. The company believes the result is increased sensitivity and specificity that will allow physicians to accurately visualize and completely remove cancers, including premalignant lesions and tumor tissues along the margins, thus reducing the chances of recurrence.
Jim Hutchens, Imagin Medical's new President Stated: "We are pleased to have our Company's shares listed on the CSE, which will give our shareholders a reflection of Imagin Medical's value as we move our technology through development to commercialization. We are excited about the future and the prospects it offers to both our shareholders and the medical industry."
For more information please visit the company's website www.imaginmedical.com, contact Bill Galine at 775-737-3292 or email billgaline@gmail.com.
About InvestmentPitch Media
InvestmentPitch Media is arguably the largest producer and distributer of video content, primarily for small and mid-cap companies. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.
CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com
copyright (c) newsfile corp. 2016